Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -113.13x is 1132% below its 4-year average of -9.18x, around the middle of its 4-year range (-202.36x–32.89x).
76.56% below its 12-month average of -64.08x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2026 (2026-03-31): -24.78x.
INTEREST COVERAGE RATIO
-113.13x
INTEREST COVERAGE RATIO AVG TTM
-64.08x
INTEREST COVERAGE RATIO AVG 3Y
-24.29x
INTEREST COVERAGE RATIO AVG 5Y
-9.18x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-76.56%
CURRENT VS 3Y AVG
-365.79%
CURRENT VS 5Y AVG
-1131.91%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-1674.59%
vs the sector median at left
China SXT Pharmaceuticals, Inc.
Market Cap
$747565.00
Interest Coverage Ratio
-113.13x
TTM Avg
-64.08x
3Y Avg
-24.29x
5Y Avg
-9.18x
Market Cap
$695428.00
Interest Coverage Ratio
-115.23x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$814420.00
Interest Coverage Ratio
-27.82x
TTM Avg
196.24x
3Y Avg
196.24x
5Y Avg
196.24x
Market Cap
$835190.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$827771.00
Interest Coverage Ratio
-8287.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$850879.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$868323.00
Interest Coverage Ratio
N/A
TTM Avg
1.00x
3Y Avg
1.00x
5Y Avg
1.00x
Market Cap
$893920.00
Interest Coverage Ratio
N/A
TTM Avg
354.05x
3Y Avg
372.60x
5Y Avg
299.52x
Market Cap
$561440.00
Interest Coverage Ratio
-9.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| China SXT Pharmaceuticals, Inc. (SXTC) | $747565.00 | -113.13x | -64.08x | -24.29x | -9.18x |
| CDT Equity Inc. (CDT)vs › | $695428.00 | -115.23x | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $814420.00 | -27.82x | 196.24x | 196.24x | 196.24x |
| Decoy Therapeutics Inc. (DCOY)vs › | $835190.00 | N/A | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $827771.00 | -8287.21x | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $850879.00 | N/A | N/A | N/A | N/A |
| Sunshine Biopharma, Inc. (SBFM)vs › | $868323.00 | N/A | 1.00x | 1.00x | 1.00x |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A | 354.05x | 372.60x | 299.52x |
| HCW Biologics Inc. (HCWB)vs › | $561440.00 | -9.00x | N/A | N/A | N/A |
| VivoSim Labs, Inc. (VIVS)vs › | $518863.00 | -935.33x | N/A | N/A | N/A |
Interest Coverage
-113.1x
Debt/Equity
0.04
Current Ratio
7.93
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -24.78x |
| 2025-12-31 | -24.78x |
| 2025-09-30 | -202.36x |
| 2025-03-31 | -4.38x |
| 2024-12-31 | -4.38x |
| 2024-09-30 | -3.50x |
| 2024-06-30 | -3.50x |
| 2024-03-31 | 1.28x |
| 2023-12-31 | 32.89x |
| 2023-09-30 | -13.89x |
| 2023-03-31 | -19.76x |
| 2022-09-30 | -2.99x |
| 2022-03-31 | -0.32x |
| 2020-03-31 | 0.13x |
| 2019-03-31 | -147.62x |
| 2018-09-30 | 442.31x |
| 2018-03-31 | 236.45x |
| 2017-12-31 | 2718.82x |
